Skip to content
Search AI Powered

Latest Stories

NY Cannabis Insider To Host State's First Industry "Summit" on May 18

NY Cannabis Insider to Host State's First Cannabis Industry Summit on May 18, 2023
NY Cannabis Insider to Host State's First Cannabis Industry Summit on May 18, 2023

NY Cannabis Insider is set to host the state's first Cannabis Industry Summit & Conference on May 18, 2023, at The Desmond Hotel in Albany, New York. The summit aims to identify challenges and propose solutions in the burgeoning New York cannabis industry. The conference will bring together industry professionals, including growers, processors, retailers, attorneys, consultants, and politicians, for a day of bluntness and problem-solving.

Conference organizers laid out a list of 10 "Problems" Facing the Industry that they anticipate will be the primary topics of conversation at the event. These include:


1. Problem #1: There aren’t enough legal recreational cannabis dispensaries open across the state.

This means farmers and processors have nowhere to sell their crop; ancillary service providers (accountants, attorneys, real estate agents, etc.) have no businesses to service; and the illicit market continues to thrive and outperform the legal industry.  

2. Problem #2: DASNY and its fund managers have raised $0 for the Conditional Adult-Use Retail Dispensary program.

The Dormitory Authority of the State of NY and its fund managers were supposed to have raised $150M from private investors by Sept. 1, 2022. This is money that is supposed to pay for the build outs and loans for CAURD licensees. To date, none of it has been raised.  

3. Problem #3: DASNY is competing against CAURD licensees for locations.

CAURD licensees who don’t want a DASNY store or support from DASNY’s fund must still get their location approved by the agency to make sure it doesn’t conflict with a site the agency is negotiating.  

4. Problem #4: June 1 deadline.

Adult-Use Conditional Cultivators and Processors can only distribute their products to retailers until June 1, 2023. The OCM hasn’t yet set rules for legal distributors, let alone began the licensing process. If there’s no legislative fix by June 1, there’s no way legally to get product from the supply tier to the retail tier.

5. Problem #5: Crumbling medical program

Seven years after medical sales began, there are only 38 medical dispensaries across the state of New York. The medical companies are suing the state over the CAURD program and their inability to enter the recreational market, and those companies are also laying off workers and cutting hours. At the end of the day, it’s the state’s patients who suffer from a lack of access, product types and affordability.   

6. Problem #6: The 4/20 bill

Assemblywoman Donna Lupardo and Senator Michelle Hinchey have introduced legislation that would allow cultivators to sell their products directly to consumers until Sept. 30, 2023. However, this legislation has stoked division between CAURD licensees and growers, and may not even be feasible given the time constraints and lack of capital among growers to institute a “mini retail store” on their property. 

7. Problem #7: Enforcement

Gov. Kathy Hochul’s enforcement bill has made it into this year’s budget. It aims to increase fines against unlicensed businesses and gives broader authorities to OCM and the Department of Taxation and Finance. But how likely is it to work? And will this effort target Black and brown business owners, reopen the War on Drugs, or miss an opportunity for onboarding these businesses and their tax revenues? 

8. Problem #8: Lack of communication

Whether it’s with OCM, DASNY or among each other, NY’s cannabis industry lacks the communication avenues necessary to enact meaningful dialogue and an exchange of ideas. Those in the industry often feel they’re getting nowhere with OCM, DASNY is a black box that answers to no one, and supply tiers are often separated both by geographical distance and motivations.  

9. Problem #9: Legacy

How does the legacy industry successfully onboard into legal without necessary support, financial aid, banking, and other services? Is that a priority for this industry?  

10. Problem #10: ???

What are the other problems we’re missing? 


In a unique twist, conference organizers partnered up with a professional mediation firm to help guide discussions around these problems and frustrations that industry members are experiencing here in New York State. Attendees will have an opportunity to speak openly and have their voices heard. After diving deep into the issues, we'll spend the afternoon finding solutions and ways to solve some of the most pressing issues presented.

Concurrent to the open forum, the conference will also host informative breakout sessions where attendees can learn more about what's next in the industry and best practices for cannabis business owners

In addition to the facilitated forum, there will be panel discussions throughout the day in a secondary room focused on retail operations, current regulations, timelines, the medical program, best practices for startups, and other topics. Attendees can avail of lightning-round business consultations, multiple networking opportunities, lunch, happy hour, and much more.

The NY Cannabis Insider Industry Summit is an all-day event that features on-site networking, and access to thought leaders and experts in the cannabis industry. The general admission ticket, priced at $195, provides attendees with all-access to the event. Readers of The Bluntness can save 15% off of the ticket by using code. - THEBLUNTNESS - when registering! Here is the link to the event websiteand direct link to the ticketing page.

The summit is an excellent opportunity to learn about what community members are doing and seeing in the industry. Lucas McCann, a 2022 event participant, said, "NY Cannabis Insider events are important to learn about what community members are doing and seeing in the industry because they draw stakeholders out."

The summit is the first cannabis "summit" of 2023 in the state, with two additional full-day conferences happening in Buffalo on September 21 and in White Plains/Greater NYC on November 15. These events are attended by industry professionals, entrepreneurs, and key stakeholders in the state's nascent industry, as well as those from cannabis-adjacent businesses such as legal, security, retail, banking, finance, construction, engineering, business consultation, marketing and medical expertise.

Space is limited at each event, and sponsorships are available. Those interested in sponsorship opportunities to reach this audience can contact Lindsay Wickham at lwickham@advancemediany.com.

The Bluntness is an official media sponsor of the NY Cannabis Insider Conference & Summit.

More For You

Discover the Apple Fritter Strain: The Sweet Hybrid - The Bluntness

Discover the Apple Fritter Strain: The Sweet Hybrid - The Bluntness

Apple Fritter: Sweet & Potent Hybrid

Introduction: Discovering the Apple Fritter Strain

Apple Fritter has quickly become a fan favorite in the cannabis community, known for its delightful flavor profile and potent effects. This balanced hybrid strain, believed to be a cross between Sour Apple and Animal Cookies, offers a unique blend of sweetness and strength that appeals to both recreational users and medical patients alike.

If you’re in search of an intensely sweet and euphoric strain, look no further than Apple Fritter. This award-winning cannabis strain is highly regarded for its potent effects and delightful flavors.

Keep ReadingShow less
a reaction to a great compliment
Why compliments matter.
Giphy

Compliments: The Power Move

There’s something oddly revolutionary about giving someone a compliment these days. Not the hollow, “Nice shirt, bro,” kind. I mean a real, unfiltered, bone-deep acknowledgment of something another human being is doing right. A small moment of connection that—let’s be honest—we’re all too stingy with.

And that’s a shame. Because in a world addicted to criticism and keyboard jockeys, the compliment is punk rock. It disrupts. It challenges cynicism. It rewires the way we see each other—and ourselves.

Keep ReadingShow less
What is Moon Rocks Weed? - The Bluntness
What is Moon Rocks Weed? - The Bluntness
What is Moon Rocks Weed? - The Bluntness

Moon Rock Weed: Out of This World

What is Moon Rock Weed?

Definition and Composition with Hash Oil

Marijuana moon rocks are a unique and highly potent cannabis product that combines multiple forms of cannabis into one extraordinary item. The creation process begins with high-quality cannabis buds, which are then coated in hash oil—a concentrated form of cannabis extract. This sticky, oil-covered bud is subsequently rolled in kief, a collection of resin glands found on cannabis flowers. The result is a product that boasts THC concentrations of 50% or higher, far surpassing the typical 15-30% found in standard cannabis strains. This combination of cannabis buds, hash oil, and kief makes moon rocks an exceptionally strong and sought-after product in the cannabis community.

History and Rise to Fame

The creation of marijuana moon rocks is credited to West Coast rapper Kurupt, who brought this potent product into the limelight in the mid-2010s through his brand, Kurupt’s Moonrock. Since their introduction, moon rocks have garnered a reputation as a premium cannabis product, often likened to the “champagne” of the marijuana world. Marijuana moon rocks stand as a symbol of both the uniqueness and evolution within the cannabis industry, representing not only high potency but also the creativity in cannabis culture. Their rise to fame has been fueled by their powerful effects and unique composition, making them a favorite among cannabis enthusiasts. The combination of celebrity endorsement and the product’s exceptional potency has solidified moon rocks’ status as a top-tier choice for those seeking an elevated cannabis experience.

Keep ReadingShow less
FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

Photo by Wesley Tingey on Unsplash

Landmark PTSD Cannabis OK

For years, military veterans suffering from post-traumatic stress disorder (PTSD) have sought alternative treatments beyond traditional pharmaceuticals. Now, after years of regulatory hurdles and advocacy, the U.S. Food and Drug Administration (FDA) has approved a groundbreaking Phase 2 clinical trial to study the effects of smoked marijuana on veterans with moderate to severe PTSD. Funded by tax revenue from Michigan's legal cannabis sales, this research represents a monumental step toward validating cannabis as a legitimate treatment option for PTSD.

PTSD affects millions of veterans, with many turning to medical marijuana for relief. Anecdotal evidence from veterans suggests that cannabis can alleviate anxiety, improve sleep, and reduce the emotional intensity of traumatic memories. Yet, despite its inclusion in many state-level medical marijuana programs, rigorous clinical data supporting its efficacy has been sparse.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less